Tag:
Oregon Health & Science University Knight Cancer Institute
Latest Headlines
Latest Headlines
PARP inhibitors could aid larger ovarian cancer patient population
PARP inhibitors are a promising new class of drugs thought to be an effective weapon against ovarian cancer, among others. But scientists have asserted that no more than 15% of women with the
